监督运动疗法联合辅助化疗提高胰腺癌S-1完成率
主要终点完成率达93%,超过预设阈值53%(p < 0.001),且安全性可接受,衰弱状态改善。
要点
- 监督运动联合S-1辅助化疗完成率达93%,显著超过53%阈值。
- S-1相对剂量强度中位数为100.0%,方案安全可耐受。
- 运动疗法可改善衰弱状态,Kihon与G8评分显著改善。
核心结论
- 胰腺癌术后辅助化疗联合监督运动疗法可提高S-1完成率。
主要发现
- S-1完成率为93%,超过阈值53%(p < 0.001)。
- S-1相对剂量强度中位数100.0(95%CI 95.9–100.0)。
- 中位无复发生存期20.4个月,中位总生存期未达到。
- Kihon清单评分显著下降(p = 0.002),G8问卷评分显著升高(p < 0.001)。
- 仅1例3级发热性中性粒细胞减少,无其他严重不良事件。
关键数值与推荐
- 主要终点S-1完成率93% vs 阈值53%(p < 0.001)。
- S-1相对剂量强度中位数100.0(95%CI 95.9–100.0)。
- 中位无复发生存期20.4个月,中位总生存期未达到。
- Kihon清单评分变化p = 0.002,G8问卷评分变化p < 0.001。
- 肌肉量、体脂量、体脂百分比及CONUT评分变化均具统计学意义。
临床怎么用
- 对胰腺癌术后接受S-1辅助化疗患者可考虑联合监督运动疗法以提高完成率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Improvement of the completion rate of postoperative adjuvant chemotherapy is a key to obtaining favorable prognosis in patients who undergo macroscopically curative pancreatectomy for pancreatic ductal adenocarcinoma. STUDY DESIGN: This study is a prospective single-center phase II trial that aimed to examine whether a supervised exercise therapy for pancreatic ductal adenocarcinoma improved the completion rate of S-1 adjuvant chemotherapy in the development of a tolerable and effective exercise plan for patients undergoing adjuvant therapy. RESULTS: Forty-three patients were included in the study. The completion rate of S-1 therapy, the primary endpoint, was 93%, which exceeded the threshold completion rate of 53% (p < 0.001). As secondary endpoints, the relative dose intensity of S-1 was 100.0 [95.9 to 100.0] (median [interquartile range]), the median recurrence-free survival was 20.4 months, and the median overall survival was not reached, confirming the safety of the protocol treatment. Regarding frailty status, there was significant decrease in the Kihon checklist score (p = 0.002) and significant increase in G8 questionnaire score (p < 0.001), indicating that exercise therapy reduced frailty. There were no incidences of serious adverse events except for 1 case of grade 3 febrile neutropenia. The differences between before/after therapy (between 6 months/baseline) of mean muscle mass, mean body fat mass, mean body fat percentage, and mean controlling nutrition status score were 1.52 (p < 0.001), -1.18 (p = 0.007), -2.47 (p < 0.001), and -0.59 (p = 0.006), respectively. CONCLUSIONS: Adjuvant chemotherapy combined with supervised exercise therapy for pancreatic ductal adenocarcinoma was confirmed to improve the completion rate of S-1 adjuvant chemotherapy.
引用
- Okada KI, Kouda K, Kawai M, et al. Supervised Exercise Therapy and Adjuvant Chemotherapy for Pancreatic Cancer: A Prospective, Single-Arm, Phase II Open-Label, Nonrandomized, Historically Controlled Study. J Am Coll Surg. 2022. PMID: 36102519. doi:10.1097/XCS.0000000000000408
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。